Top 10 Companies in the (S)-2-Octanol Market (2026): Market Leaders Driving Global Chiral Chemistry

MARKET INSIGHTS

Global (S)-2-Octanol market size was valued at USD 28.4 million in 2025. The market is projected to rise from USD 29.8 million in 2026 to USD 46.2 million by 2034, reflecting a CAGR of 5.6 % over the forecast period.

(S)-2‑Octanol is a chiral secondary alcohol (C₈H₁₈O) noted for its optical activity and a mild, mushroom‑like aroma. As the (S)-enantiomer of 2‑Octanol, it is a pivotal building block in asymmetric synthesis, underpinning the manufacture of pharmaceuticals, agrochemicals, and specialty fragrances. Its enantiomeric purity is critical for biological efficacy and regulatory compliance, positioning it as a high‑value intermediate in advanced chemical processes.

The market is witnessing steady growth, spurred primarily by rising demand for enantiopure compounds in pharmaceutical manufacturing and increasing adoption of chiral intermediates in agrochemical formulations. Expanding applications in the flavor and fragrance sector, coupled with investments in green chemistry and biocatalytic production methods, reinforce momentum. Key producers include Sigma‑Aldrich (MilliporeSigma), Tokyo Chemical Industry Co., Ltd. (TCI), and Alfa Aesar, among others.

(S)-2‑Octanol Market – View in Detailed Research Report

Top 10 Companies in the (S)-2‑Octanol Market (2026)

1. BASF SE

Headquarters: Ludwigshafen, Germany
Key Offering: Enantiomerically pure (S)-2‑Octanol for pharmaceutical intermediates and fragrance applications

BASF’s integrated supply chain, from octene sourcing to catalytic resolution, delivers consistent >99 % ee grades. The company’s focus on process scalability and cost‑effective enzymatic resolutions keeps it ahead in the high‑purity segment.

Sustainability & Growth Initiatives: Investment in bio‑based feedstocks and continuous‑flow asymmetric catalysis to reduce carbon footprint.

• Biocatalytic resolution unit in Ludwigshafen slated for 2027.
• Partnership with academic centers for enzyme engineering.
• Targeted reduction of solvent use by 20 % by 2030.

2. Evonik Industries AG

Headquarters: Essen, Germany
Key Offering: High‑purity (S)-2‑Octanol for pharma‑grade synthesis and fine chemicals

Evonik leverages proprietary chiral catalysts to produce >99.5 % ee material, supporting next‑generation drug development. Its contract‑manufacturing model ensures rapid response to client R&D cycles.

Sustainability & Growth Initiatives: Expansion of green chemistry programs and waste minimization strategies.

• Launch of a closed‑loop recycling pilot for chiral solvents.
• Investment in renewable energy for production sites.
• Commitment to zero‑waste‑to‑landfill by 2035.

3. Daicel Corporation

Headquarters: Tokyo, Japan
Key Offering: Fermentation‑derived (S)-2‑Octanol for fragrance and flavor markets

Daicel’s fermentation platform delivers cost‑competitive, high‑purity chiral alcohols, enabling premium fragrance blends that meet clean‑label standards.

Sustainability & Growth Initiatives: Bioprocess optimization and renewable feedstock sourcing.

• Scale‑up of bioreactor capacity by 30 % in 2028.
• Partnerships with Japanese agricultural cooperatives for bio‑octene feedstock.
• Reduction of CO₂ emissions by 15 % per ton of product.

4. Takasago International Corporation

Headquarters: Osaka, Japan
Key Offering: Premium (S)-2‑Octanol for high‑end fragrances and cosmetics

Takasago’s focus on aroma‑specific enantiomeric purity supports luxury fragrance brands seeking unique scent profiles.

Sustainability & Growth Initiatives: Green chemistry integration and circular economy projects.

• Implementation of solvent‑free resolution processes.
• Collaboration with fragrance houses to develop sustainable scent libraries.
• Targeted reduction of VOC emissions by 25 % by 2035.

5. DSM‑Firmenich

Headquarters: Geneva, Switzerland
Key Offering: (S)-2‑Octanol for flavor and fragrance synthesis

DSM‑Firmenich combines chiral synthesis expertise with flavor expertise, delivering tailored enantiopure intermediates for food and beverage applications.

Sustainability & Growth Initiatives: Integration of renewable resources and life‑cycle assessment.

• Launch of a renewable‑feedstock pilot in 2029.
• Adoption of life‑cycle assessment for all chiral intermediates.
• Goal of 30 % renewable content in product portfolio by 2035.

6. Lonza Group Ltd

Headquarters: Basel, Switzerland
Key Offering: Contract manufacturing of (S)-2‑Octanol for pharma and fine chemical sectors

Lonza’s precision manufacturing ensures strict optical purity, supporting pharmaceutical companies with complex chiral synthesis needs.

Sustainability & Growth Initiatives: Energy efficiency upgrades and waste‑to‑energy projects.

• Installation of high‑efficiency heat recovery systems.
• Partnership with local utilities for waste‑to‑energy conversion.
• Reduction of energy intensity by 18 % by 2030.

7. Siegfried Holding AG

Headquarters: Lenzburg, Switzerland
Key Offering: (S)-2‑Octanol for specialty chemical applications

Siegfried’s focus on high‑purity chiral intermediates supports advanced materials and fine chemical development.

Sustainability & Growth Initiatives: Green chemistry and circular supply chain.

• Implementation of closed‑loop chiral solvent recovery.
• Partnership with material science institutes for sustainable product development.
• Targeted 20 % reduction in process water consumption by 2032.

8. Tokyo Chemical Industry Co., Ltd.

Headquarters: Tokyo, Japan
Key Offering: (S)-2‑Octanol for pharmaceutical intermediates and agrochemical formulations

TCI’s advanced catalytic processes deliver high‑purity chiral alcohols, supporting diverse end‑users.

Sustainability & Growth Initiatives: Renewable energy adoption and waste minimization.

• Installation of solar PV arrays covering 30 % of electricity needs.
• Implementation of a zero‑waste‑to‑landfill policy by 2035.
• Reduction of hazardous waste by 25 % through process redesign.

9. Wacker Chemie AG

Headquarters: Munich, Germany
Key Offering: (S)-2‑Octanol for industrial and pharmaceutical applications

Wacker’s catalytic platform delivers scalable production of enantiomerically pure (S)-2‑Octanol, supporting both bulk and specialty markets.

Sustainability & Growth Initiatives: Process intensification and carbon capture.

• Deployment of process intensification units to reduce footprint.
• Investigation of CO₂ capture for octene synthesis.
• Targeted 15 % reduction in process emissions by 2034.

10. Mitsubishi Gas Chemical Company, Inc.

Headquarters: Tokyo, Japan
Key Offering: (S)-2‑Octanol for pharmaceutical intermediates and fine chemicals

Mitsubishi’s integrated petrochemical base supports efficient supply of raw materials for chiral synthesis, enabling competitive pricing.

Sustainability & Growth Initiatives: Energy efficiency and renewable feedstock development.

• Implementation of high‑efficiency catalytic reactors.
• Partnership with renewable gas producers for bio‑octene feedstock.
• Goal of 10 % renewable content in product mix by 2035.

Download FREE Sample Report

Get Full Report

Outlook

Projected market growth to USD 46.2 million by 2034 reflects a sustained demand for enantiopure intermediates, particularly in pharmaceutical and fragrance sectors. The continued expansion of biocatalytic processes and the shift toward bio‑based feedstocks are expected to moderate production costs and enhance optical purity, supporting a balanced supply‑demand trajectory.

Future Trends

• Accelerated adoption of enzyme‑mediated resolutions, reducing energy consumption and solvent usage.
• Integration of AI‑driven catalyst design to accelerate process optimization.
• Expansion of green chemistry initiatives, including the use of renewable octene feedstocks.
• Growing demand for high‑purity chiral intermediates in emerging therapeutic areas such as oncology and immuno‑oncology.
• Increased regulatory focus on sustainability metrics for chiral chemicals.